Author Index

Search or browse for an author across our entire electronic archive

Search results for: M
Results 21 - 30 of 2592 shown below

  • Märten, A

    G Reinhard, A Märten, S M Kiske, F Feil, T Bieber and I G H Schmidt-Wolf

    Generation of dendritic cell-based vaccines for cancer therapy

    doi:10.1038/sj.bjc.6600316

  • J Schmidt, T Welsch, D Jäger, P F Mühlradt, M W Büchler and A Märten

    Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial

    advance online publication, 2007-07-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603903

  • Méchinaud, F

    N Jourdan-Da Silva, Y Perel, F Méchinaud, E Plouvier, V Gandemer, P Lutz, J P Vannier, J L Lamagnére, G Margueritte, P Boutard, A Robert, C Armari, M Munzer, F Millot, L de Lumley, C Berthou, X Rialland, B Pautard, D Hémon and J Clavel

    Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia

    doi:10.1038/sj.bjc.6601384

  • Mégraud, F

    N Broutet, M Plebani, C Sakarovitch, P Sipponen and F Mégraud

    Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

    doi:10.1038/sj.bjc.6600877

  • Méjean, A

    S Gad, S H Lefèvre, S K Khoo, S Giraud, A Vieillefond, V Vasiliu, S Ferlicot, V Molinié, Y Denoux, N Thiounn, Y Chrétien, A Méjean, M Zerbib, G Benoît, J M Hervé, G Allègre, B Bressac-de Paillerets, B T Teh and S Richard

    Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma

    advance online publication, 2006-11-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603492

  • S Gad, S H Lefèvre, S K Khoo, S Giraud, A Vieillefond, V Vasiliu, S Ferlicot, V Molinié, Y Denoux, N Thiounn, Y Chrétien, A Méjean, M Zerbib, G Benoît, J M Hervé, G Allègre, B Bressac-de Paillerets, B T Teh and S Richard

    Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma

    doi:10.1038/sj.bjc.6603733

  • Ménégoz, F

    O Dejardin, C Herbert, M Velten, A Buemi, F Ménégoz, N Maarouf and G Launoy

    Social and geographical factors influencing the delay in treatment for colorectal cancer

    advance online publication, 2004-09-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602170

  • Ménétrier-Caux, C

    C Ménétrier-Caux, C Bain, M C Favrot, A Duc and J Y Blay

    Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes

    doi:10.1038/sj.bjc.6690021

  • Ménard, S

    A Balsari, P Casalini, R Bufalino, F Berrino and S Ménard

    Role of hormonal risk factors in HER2-positive breast carcinomas

    doi:10.1038/sj.bjc.1117-02ep

  • A Balsari, P Casalini, R Bufalino, F Berrino and S Ménard

    Role of hormonal risk factors in HER2-positive breast carcinomas

    doi:10.1038/sj.bjc.6600844

  • A Balsari, C Rumio, D Morelli, L Sfondrini, E Nardini, I Barajon and S Ménard

    Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice

    doi:10.1054/bjoc.2001.2188

  • Méndez, F

    N Muñoz, G Hernandez-Suarez, F Méndez, M Molano, H Posso, V Moreno, R Murillo, M Ronderos, C Meijer and Á Muñoz

    Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604972

  • Møller, B

    H Møller, L Fairley, V Coupland, C Okello, M Green, D Forman, B Møller and F Bray

    The future burden of cancer in England: incidence and numbers of new patients in 2020

    advance online publication, 2007-05-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603746

  • Møller, H

    R H Jack, M C Gulliford, J Ferguson and H Møller

    Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?

    doi:10.1038/sj.bjc.6600831

  • D Robinson, C M J Bell, H Møller and I Basnett

    Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England

    doi:10.1038/sj.bjc.6601149

  • R Roychoudhuri, H Evans, D Robinson and H Møller

    Radiation-induced malignancies following radiotherapy for breast cancer

    advance online publication, 2004-08-03 00:00:00.000;

    doi:10.1038/sj.bjc.6602084

  • R H Jack, M C Gulliford, J Ferguson and H Møller

    Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services?

    doi:10.1038/sj.bjc.6602247

  • A Newnham, J Harris, H S Evans, B G Evans and H Møller

    The risk of cancer in HIV-infected people in southeast England: a cohort study

    advance online publication, 2004-12-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602273

  • J H Olsen, S Friis, K Frederiksen, J K McLaughlin, L Mellemkjaer and H Møller

    Atypical cancer pattern in patients with Parkinson's disease

    advance online publication, 2004-12-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602279

  • S K Maitra, H Gallo, C Rowland-Payne, D Robinson and H Møller

    Second primary cancers in patients with squamous cell carcinoma of the skin

    advance online publication, 2004-12-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602306

  • D Robinson, T Massey, E Davies, R H Jack, A Sehgal and H Møller

    Waiting times for radiotherapy: variation over time and between cancer networks in southeast England

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602463

  • E Davies, K M Linklater, R H Jack, L Clark and H Møller

    How is place of death from cancer changing and what affects it? Analysis of cancer registration and service data

    advance online publication, 2006-08-15 00:00:00.000;

    doi:10.1038/sj.bjc.6603305

  • J Cuzick, G Fisher, M W Kattan, D Berney, T Oliver, C S Foster, H Møller, V Reuter, P Fearn, J Eastham and P Scardino

    Long-term outcome among men with conservatively treated localised prostate cancer

    doi:10.1038/sj.bjc.6603411

  • D Robinson, H Møller and A Horwich

    Mortality and incidence of second cancers following treatment for testicular cancer

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603589

  • N Patel, R Adatia, A Mellemgaard, R Jack and H Møller

    Variation in the use of chemotherapy in lung cancer

    advance online publication, 2007-03-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603659

  • H Møller, L Fairley, V Coupland, C Okello, M Green, D Forman, B Møller and F Bray

    The future burden of cancer in England: incidence and numbers of new patients in 2020

    advance online publication, 2007-05-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603746

  • D Robinson, L Holmberg and H Møller

    The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604524

  • V H Coupland, P Chapman, K M Linklater, A Sehgal, H Møller and E A Davies

    Trends in the epidemiology of larynx and lung cancer in south-east England, 1985–2004

    advance online publication, 2008-11-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604787

  • R H Jack, E A Davies and H Møller

    Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England

    advance online publication, 2009-01-06 00:00:00.000;

    doi:10.1038/sj.bjc.6604852

  • D Robinson, V Coupland and H Møller

    An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England

    advance online publication, 2009-01-20 00:00:00.000;

    doi:10.1038/sj.bjc.6604871

  • D Robinson, C Renshaw, C Okello, H Møller and E A Davies

    Suicide in cancer patients in South East England from 1996 to 2005: a population-based study

    advance online publication, 2009-05-26 00:00:00.000;

    doi:10.1038/sj.bjc.6605110

  • J Maddams, D Brewster, A Gavin, J Steward, J Elliott, M Utley and H Møller

    Cancer prevalence in the United Kingdom: estimates for 2008

    advance online publication, 2009-06-30 00:00:00.000;

    doi:10.1038/sj.bjc.6605148

  • C S Foster, A R Dodson, L Ambroisine, G Fisher, H Møller, J Clark, G Attard, J De-Bono, P Scardino, V E Reuter, C S Cooper, D M Berney and J Cuzick

    Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

    advance online publication, 2009-08-25 00:00:00.000;

    doi:10.1038/sj.bjc.6605227

  • H Møller, K M Linklater and D Robinson

    A visual summary of the EUROCARE-4 results: a UK perspective

    doi:10.1038/sj.bjc.6605400

  • H S Evans, C M Lewis, D Robinson, C M J Bell, H Møller and S V Hodgson

    Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England

    doi:10.1054/bjoc.2000.1603